252 related articles for article (PubMed ID: 28272234)
1. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.
Kwon JW; Jee D; La TY
Medicine (Baltimore); 2017 Mar; 96(10):e6263. PubMed ID: 28272234
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
3. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
Goto A; Inatani M; Inoue T; Awai-Kasaoka N; Takihara Y; Ito Y; Fukushima M; Tanihara H
J Glaucoma; 2013 Sep; 22(7):572-6. PubMed ID: 22407392
[TBL] [Abstract][Full Text] [Related]
5. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623
[TBL] [Abstract][Full Text] [Related]
6. The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy.
Sun D; Lin Y; Zeng R; Yang Z; Deng X; Lan Y
Eur J Ophthalmol; 2021 Nov; 31(6):3057-3067. PubMed ID: 33334171
[TBL] [Abstract][Full Text] [Related]
7. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
[TBL] [Abstract][Full Text] [Related]
8. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy.
Park UC; Park KH; Kim DM; Yu HG
J Glaucoma; 2011 Sep; 20(7):433-8. PubMed ID: 20852440
[TBL] [Abstract][Full Text] [Related]
9. Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study.
Liang X; Zhang Y; Li YP; Huang WR; Wang JX; Li X
Diabetes Ther; 2019 Oct; 10(5):1801-1809. PubMed ID: 31321746
[TBL] [Abstract][Full Text] [Related]
10. Rubeosis iridis after vitrectomy for diabetic retinopathy.
Helbig H; Kellner U; Bornfeld N; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):730-3. PubMed ID: 9801886
[TBL] [Abstract][Full Text] [Related]
11. 23G Minimally Invasive Vitrectomy Combined with Glaucoma Drainage Valve Implantation and Phacoemulsification Cataract Extraction for Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Shi X; Dong N; Liang Y; Zheng L; Wang X
Comput Math Methods Med; 2022; 2022():7393661. PubMed ID: 35966245
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
[TBL] [Abstract][Full Text] [Related]
13. Visual prognosis and surgical timing of Ahmed glaucoma valve implantation for neovascular glaucoma secondary to diabetic vitrectomy.
Lee JS; Lee YB; Kim TW; Park KH
BMC Ophthalmol; 2023 Mar; 23(1):107. PubMed ID: 36932350
[TBL] [Abstract][Full Text] [Related]
14. Pars plana Ahmed implantation combined with 23-gauge vitrectomy for refractory neovascular glaucoma in diabetic retinopathy.
Jeong HS; Nam DH; Paik HJ; Lee DY
Korean J Ophthalmol; 2012 Apr; 26(2):92-6. PubMed ID: 22511834
[TBL] [Abstract][Full Text] [Related]
15. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
16. Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy.
Wand M; Madigan JC; Gaudio AR; Sorokanich S
Ophthalmic Surg; 1990 Feb; 21(2):113-8. PubMed ID: 2330190
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
Falavarjani KG; Modarres M; Nazari H
Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
[TBL] [Abstract][Full Text] [Related]
18. Neovascular glaucoma following vitrectomy for diabetic eye disease.
Summanen P
Acta Ophthalmol (Copenh); 1988 Feb; 66(1):110-6. PubMed ID: 3364164
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
Sakamoto M; Hashimoto R; Yoshida I; Ubuka M; Maeno T
Clin Ophthalmol; 2018; 12():2323-2329. PubMed ID: 30532517
[TBL] [Abstract][Full Text] [Related]
20. Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.
Nakatake S; Yoshida S; Nakao S; Arita R; Yasuda M; Kita T; Enaida H; Ohshima Y; Ishibashi T
BMC Ophthalmol; 2014 Apr; 14():55. PubMed ID: 24766841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
